- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06907589
A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care (OLIMPIA)
March 26, 2025 updated by: Filippo Cavallo, Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
The present study aims to use the SensMode System - a system composed of wearable devices for upper and lower limb movement analysis and electronic device for data acquisition and processing - on healthy subjects, subjects with idiopathic hyposmia, patients with Parkinson's disease, and subjects with de-novo drug-naïve extrapyramidal syndrome.
The purpose is to identify normative data of objective motor measures obtained with such a system, as well as to increase knowledge about the potential contribution such a solution can make to the preclinical diagnosis of Parkinson's disease and the management of patients with this disease.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Filippo Cavallo
- Phone Number: +390552758663
- Email: filippo.cavallo@santannapisa.it
Study Contact Backup
- Name: Erika Rovini
- Phone Number: +390553758663
- Email: erika.rovini@unifi.it
Study Locations
-
-
-
Firenze, Italy, 50134
- Recruiting
- Azienda Ospedaliero Universitaria Careggi
-
Contact:
- Silvia Ramat
- Phone Number: +390557947956
- Email: silvia.ramat@unifi.it
-
Firenze, Italy, 50143
- Recruiting
- IRCCS Fondazione Don Carlo Gnocchi Firenze
-
Contact:
- Gemma Lombardi
- Phone Number: +3905557393917
- Email: glombardi@dongnocchi.it
-
Massa, Italy, 54100
- Recruiting
- Ospedale Apuane AUSL Toscana Nord Ovest
-
Contact:
- Carlo Maremmani
- Phone Number: +3905854931
- Email: carlo.maremmani@uslnordovest.toscana.it
-
Milano, Italy, 20149
- Recruiting
- IRCCS Istituto Auxologico Italiano, Ospedale San Luca
-
Contact:
- Andrea Ciammola
- Phone Number: +39026191129
- Email: a.ciammola@auxologico.it
-
-
Firenze
-
Bagno a Ripoli, Firenze, Italy, 50012
- Recruiting
- Ospedale Santa Maria Annunziata AUSL Toscana Centro
-
Contact:
- Paola Vanni
- Phone Number: +390552313862
- Email: paola.vanni@uslcentro.toscana.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Healthy subjects - Inclusion Criteria:
- Adult subjects, both sexes, aged 50-80 years old
- MMSE score >= 24 absence of olfactory deficit detected on IOIT olfactory test (22). Age class 50-59 years: normal with score <=5; age class 60-69 years: normal with score <=6; age class > 70 years: normal with score <=7
- absence of neurological diseases
- absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
- expression of informed consent to participate in the study
Subjects with Parkinson's disease -- Inclusion criteria:
- adult subjects, both sexes, 50-80 years of age
- MMSE score >= 24
- subjects with Parkinson's disease in the absence of motor fluctuations and dyskinesias, or subjects with Parkinson's disease with mild motor fluctuations throughout the day, but to be examined in the ON phase and in the absence of dyskinesias
- Hoehn and Yahr stage 1, 2, 3
- absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
- expression of informed consent to participate in the study
Exclusion Criteria:
Healthy subjects - Exclusion criteria:
- denial of informed consent to participate in the study
- Presence of olfactory deficit detected on IOIT olfactory test. Age class 50-59 years: hyposmia with score >=6; age class 60-69 years: hyposmia with score >=7; age class > 70 years: hyposmia with score >=8
- body weight greater than 120 kg
- insufficient degree of cooperation
- malignant neoplasm in progress or with negative follow-up of less than 6 years
- structured joint stiffness in the upper and/or lower extremities preventing proper execution of movements
- paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury
- mono/multi/poly sensory and/or motor neuropathy
- chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
- vertiginous syndromes in the acute phase
- neurodegenerative diseases
- fever
- venous thrombosis
- cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
- spinal or joint pain of various etiologies that may affect the performance of motor exercises
- positive history of recurrent acute cervico-brachialgia and/or lumbosciatica
Subjects with Parkinson's disease - Exclusion criteria:
- Denial of informed consent to participate in the study
- Hoenn and Yahr stage 4, 5
- Patient who needs to use an aid (cane or walker) while walking or cannot walk unless aided by a person
- body weight greater than 120 kg
- insufficient degree of cooperation
- malignant neoplasm in place or with negative follow-up of less than 6 years
- structured joint stiffness in the upper and/or lower extremities that prevents proper execution of movements
- paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury mono/multi/poly sensory and/or motor neuropathy
- chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
- vertiginous syndromes in the acute phase
- neurodegenerative diseases, excluding Parkinson's disease
- fever
- venous thrombosis
- cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
- spinal or joint pain of various etiologies that may affect the performance of motor exercises
- positive history of recurrent acute cervico-brachialgia and/or low back pain
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motor Data Analysis for Healthy Subjects
All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement
|
The SensMode System includes wearable devices for upper and lower limb motion analysis.
The upper limb device, SensHand, consists of 3 sensorized elements: 2 sensorized rings to be placed at the level of the distal phalanx of the thumb and forefinger of the hand and 1 sensorized wristband to be placed at the level of the distal portion of the forearm near the wrist.
Each element of SensHand allows the acquisition of inertial data with respect to the biomechanics of the arm-forearm-wrist and the first three fingers of the hand, measuring the 3 components in space of linear acceleration, angular velocity, and magnetic field.
The lower limb device, SensFoot, is a device that integrates the same electronic components as the bracelet and is placed in a plastic housing shaped like a small rectangular parallelepiped that is placed over the shoe.
|
|
Experimental: Motor Data Analysis for patients with Parkinson's disease
All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement
|
The SensMode System includes wearable devices for upper and lower limb motion analysis.
The upper limb device, SensHand, consists of 3 sensorized elements: 2 sensorized rings to be placed at the level of the distal phalanx of the thumb and forefinger of the hand and 1 sensorized wristband to be placed at the level of the distal portion of the forearm near the wrist.
Each element of SensHand allows the acquisition of inertial data with respect to the biomechanics of the arm-forearm-wrist and the first three fingers of the hand, measuring the 3 components in space of linear acceleration, angular velocity, and magnetic field.
The lower limb device, SensFoot, is a device that integrates the same electronic components as the bracelet and is placed in a plastic housing shaped like a small rectangular parallelepiped that is placed over the shoe.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of repetitions
Time Frame: at Enrollment (T0)
|
Number of repetitions in Finger Tapping task
|
at Enrollment (T0)
|
|
Number of repetitions
Time Frame: at Enrollment (T0)
|
Number of repetitions in Thumb-ForeFinger Tapping task
|
at Enrollment (T0)
|
|
Number of repetitions
Time Frame: at Enrollment (T0)
|
Number of repetitions in Opening/Closing task
|
at Enrollment (T0)
|
|
Number of repetitions
Time Frame: at Enrollment (T0)
|
Number of repetitions in Pronosupination task
|
at Enrollment (T0)
|
|
Number of repetitions
Time Frame: at Enrollment (T0)
|
Number of repetitions in Toe Tapping task
|
at Enrollment (T0)
|
|
Number of repetitions
Time Frame: at Enrollment (T0)
|
Number of repetitions in Leg Agility task
|
at Enrollment (T0)
|
|
Number of repetitions
Time Frame: at Enrollment (T0)
|
Number of repetitions in Heel Tapping task
|
at Enrollment (T0)
|
|
Number of repetitions
Time Frame: at Enrollment (T0)
|
Number of repetitions in Heel-Toe Tapping task
|
at Enrollment (T0)
|
|
Time to Stand Up
Time Frame: at Enrollment (T0)
|
Time to stand up from a chair
|
at Enrollment (T0)
|
|
Gait Time
Time Frame: at Enrollment (T0)
|
Time to walk for 15 meters straight on
|
at Enrollment (T0)
|
|
Rotation Time
Time Frame: at Enrollment (T0)
|
Time to perform a turning of 360°
|
at Enrollment (T0)
|
|
Fundamental frequency of accelerometer signal
Time Frame: At enrollment (T0)
|
Fundamental frequency of accelerometer signal for hands resting tremor task
|
At enrollment (T0)
|
|
Fundamental frequency of accelerometer signal
Time Frame: At enrollment (T0)
|
Fundamental frequency of accelerometer signal for feet resting tremor task
|
At enrollment (T0)
|
|
Fundamental frequency of accelerometer signal
Time Frame: At enrollment (T0)
|
Fundamental frequency of accelerometer signal for hands postural tremor task
|
At enrollment (T0)
|
|
Fundamental frequency of accelerometer signal
Time Frame: At enrollment (T0)
|
Fundamental frequency of accelerometer signal for hands kinetic tremor task
|
At enrollment (T0)
|
|
Strides Number
Time Frame: at Enrollment (T0)
|
Number of strides to walk for 15 meters straight on
|
at Enrollment (T0)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 13, 2024
Primary Completion (Estimated)
January 1, 2026
Study Completion (Estimated)
January 8, 2026
Study Registration Dates
First Submitted
March 26, 2025
First Submitted That Met QC Criteria
March 26, 2025
First Posted (Actual)
April 2, 2025
Study Record Updates
Last Update Posted (Actual)
April 2, 2025
Last Update Submitted That Met QC Criteria
March 26, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OLIMPIA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Motor Data Analysis
-
Clinica Gema LeonCompleted
-
GEMA LEÓN BRAVOCompleted
-
Hospices Civils de LyonCompleted
-
Centre Hospitalier Universitaire de NiceRecruitingCentral Nervous System DiseasesFrance
-
Centre integre universitaire de sante et de services...Active, not recruitingMotoric Cognitive Risk Syndrome | Aging DisorderCanada
-
Brno University HospitalMasaryk UniversityCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
Heinrich-Heine University, DuesseldorfActive, not recruitingCardiac Imaging TechniquesGermany
-
University Hospital, Basel, SwitzerlandCompleted
-
Shandong UniversityNational Health Medical Data (North Center)Recruiting